HUTCHMED DRC Ownership
| HCM Stock | USD 17.41 0.05 0.29% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
HUTCHMED |
HUTCHMED Stock Ownership Analysis
The book value of the company was currently reported as 0.87. The company has Price/Earnings (P/E) ratio of 335.94. HUTCHMED DRC recorded a loss per share of 0.25. The entity had not issued any dividends in recent years. The firm had 1:1 split on the 30th of May 2019. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people. To learn more about HUTCHMED DRC call Weiguo BSc at 852 2121 8200 or check out https://www.hutch-med.com.Besides selling stocks to institutional investors, HUTCHMED DRC also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different HUTCHMED DRC's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align HUTCHMED DRC's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
HUTCHMED DRC Quarterly Liabilities And Stockholders Equity |
|
Less than 1% of HUTCHMED DRC are currently held by insiders. Unlike HUTCHMED DRC's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against HUTCHMED DRC's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of HUTCHMED DRC's insider trades
HUTCHMED Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as HUTCHMED DRC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HUTCHMED DRC backward and forwards among themselves. HUTCHMED DRC's institutional investor refers to the entity that pools money to purchase HUTCHMED DRC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2024-09-30 | 71 K | Hennion & Walsh Asset Management Inc | 2024-09-30 | 61.1 K | Goldman Sachs Group Inc | 2024-06-30 | 52.5 K | Dekabank Deutsche Girozentrale | 2024-06-30 | 41.4 K | Ubs Group Ag | 2024-06-30 | 35 K | Trexquant Investment Lp | 2024-06-30 | 27.1 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 24.5 K | Bellevue Group Ag | 2024-09-30 | 24 K | Alberta Investment Management Corp | 2024-09-30 | 23.9 K | Schroder Investment Management Group | 2024-06-30 | 3 M | Allianz Asset Management Ag | 2024-06-30 | 1.5 M |
HUTCHMED DRC Outstanding Bonds
HUTCHMED DRC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HUTCHMED DRC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HUTCHMED bonds can be classified according to their maturity, which is the date when HUTCHMED DRC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| CKHH 745 24 NOV 33 Corp BondUS44841SAC35 | View |
HUTCHMED DRC Corporate Filings
6K | 22nd of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 28th of June 2024 Other Reports | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.25) | Revenue Per Share 3.575 | Quarterly Revenue Growth (0.43) | Return On Assets (0.06) |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.